Vacuna recombinante multivalente de proteína de la COVID-19 contra variantes XBB de WestVac Biopharma ...Middle East

PR Newswire - News
Vacuna recombinante multivalente de proteína de la COVID-19 contra variantes XBB de WestVac Biopharma
- La primera de su clase en el mundo: La Administración Nacional de Productos Médicos de China ha aprobado para ensayos clínicos la vacuna recombinante multivalente de proteína de la COVID-19 contra las variantes XBB de WestVac Biopharma/West China Medical Center, Sichuan University...

Hence then, the article about vacuna recombinante multivalente de proteina de la covid 19 contra variantes xbb de westvac biopharma was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Vacuna recombinante multivalente de proteína de la COVID-19 contra variantes XBB de WestVac Biopharma )

Apple Storegoogle play

Last updated :

Also on site :



Latest News